Article info

Download PDFPDF
Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis

Authors

  1. Correspondence to:
    M Lunt
    Arc Epidemiology Unit, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PT, UK;mark.lunt{at}manchester.ac.uk
View Full Text

Citation

Hider SL, Silman A, Bunn D, et al
Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis

Publication history

  • Accepted March 2, 2006
  • First published March 15, 2006.
Online issue publication 
October 12, 2006

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.